United States (USA) Drug Screening Market Overview, 2028

Drug testing is widespread in the American workplace. Many employers conduct drug screenings as part of the hiring process and may also implement random or periodic testing for existing employees. Industries such as transportation, healthcare, and government contracts often have strict drug testing policies due to safety and security concerns. The United States is one of the only developed countries that routinely drug tests its workforce. According study by the Substance Abuse and Mental Health Services Administration (SAMHSA), more than 40% of full-time employed adults in the United States were drug tested in the past year. The most common types of drug tests include urine tests, hair follicle tests, blood tests, and saliva tests. Each type has its own detection window, with urine tests being the most prevalent. Employers typically conduct drug tests to ensure a safe and productive work environment. This is especially important in jobs where impairment could lead to accidents or errors, such as in transportation or healthcare. Drug testing is generally legal in the United States, and employers are within their rights to implement drug testing policies. However, there are regulations in place to protect employees from unfair practices, and the testing process must comply with federal and state laws. Many employers participate in Drug-Free Workplace programs, which are often incentivized by government agencies. These programs may include educational components, employee assistance programs, and strict drug testing protocols. Labor unions and employee advocacy groups may challenge certain aspects of drug testing policies, arguing for fair treatment, privacy protection, and adherence to employment contracts. Some critics argue that the costs associated with drug testing may outweigh the benefits, especially considering the potential for false positives and the fact that drug tests primarily detect past use rather than impairment at the time of testing. According to the research report "United States Drug Screening Market Overview, 2028," published by Bonafide Research, the United States Drug Screening market was valued around USD 2.50 Billion in 2022. There is a growing trend toward point-of-care testing, allowing for quicker and more convenient drug testing, especially in industries where rapid results are crucial. Continuous advancements in testing technologies, such as improvements in immunoassay techniques and the adoption of mass spectrometry, contribute to more accurate and reliable results. The incorporation of AI and data analytics is enhancing the interpretation of drug testing results, providing more insights into patterns, trends, and potential risks within organizations. Hair follicle testing is gaining popularity due to its longer detection window, providing insights into an individual's drug use history over an extended period. Oral fluid testing is on the rise due to its non-invasiveness and ability to detect recent drug use. It is particularly relevant in situations where immediate detection is essential. Mobile testing units are becoming more common, allowing employers to conduct on-site testing efficiently. This is particularly useful in industries where employees work in remote locations. Wellness apps and platforms are being integrated into drug testing programs to provide employees with resources and support related to substance abuse prevention and treatment. The market is seeing increased availability of at-home drug testing kits, allowing individuals to self-administer tests with samples sent to laboratories for analysis. This trend aligns with the growing demand for convenience. Drug testing in sports is evolving, with a focus on staying ahead of new performance-enhancing substances. The incorporation of advanced testing methods and broader panels reflects the commitment to maintaining fair play.

In terms of Product and Service the market is bifurcate into Consumables, Analytical Instruments, Rapid Testing Devices and Drug Screening Service. The consumables segment often includes testing kits and collection devices used for high-volume drug testing, especially in workplace testing programs, law enforcement, and healthcare settings. The demand for consumables is directly influenced by the frequency and volume of drug testing required. Point-of-care testing, which involves immediate on-site testing using rapid test kits, has gained popularity. These kits are a significant component of the consumables segment, allowing for quick and convenient drug testing without the need for samples to be sent to a laboratory. The consumables segment includes a diverse range of testing kits designed to detect different drugs of abuse. The availability of testing kits for various substances, including marijuana, cocaine, opioids, amphetamines, etc., caters to the diverse needs of different industries and testing scenarios. The consumables segment evolves to meet the demand for testing panels that cover a broader range of substances. As the landscape of substance abuse changes, consumables providers introduce new testing panels to address emerging trends. Furthermore, based on sample type, Breath sample testing is a convenient and simple process. The collection of breath samples is quick and does not require special facilities or trained medical personnel. This simplicity makes it suitable for a variety of testing scenarios, including workplace testing, law enforcement, and drug rehabilitation programs. One of the key advantages of breath sample testing is its non-invasive nature. Unlike blood or urine tests, which require the collection of bodily fluids, breath samples are obtained by simply having the individual exhale into a collection device. This non-invasiveness makes it more comfortable for individuals undergoing testing. Breath sample testing allows for real-time monitoring of recent drug use. Unlike urine or blood tests, which may detect drug metabolites over a longer period, breath tests focus on detecting substances that are currently in the bloodstream. This real-time aspect is valuable in certain testing contexts. Based on end user the market is categorized into Laboratories, Workplaces, Hospitals and Others. Workplace safety is a top priority for employers, especially in industries where impaired performance can lead to accidents and injuries. Implementing drug testing programs helps ensure that employees are not under the influence of substances that could compromise safety. Some insurance providers offer reduced premiums for employers with drug-free workplace programs in place. Employers implementing drug testing may benefit from cost savings on insurance premiums, providing a financial incentive for the adoption of drug screening programs. Employers may face legal and liability concerns if an employee under the influence of drugs causes harm to themselves, colleagues, or others. Implementing drug testing programs can help employers demonstrate due diligence in providing a safe work environment and reduce legal risks. Random and periodic drug testing of employees is a common practice in many workplaces. These tests are designed to deter substance abuse, as employees are aware that they may be subject to testing at any time. Random testing also helps identify and address potential issues early on. Considered in this report: • Geography: United States • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report: • United States Drug Screening market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation By Product and Service • Consumables • Analytical Instruments • Rapid Testing Devices • Drug Screening Service By Sample Type • Urine Samples • Breath Samples • Hair Samples • Oral Fluid Samples • Other Samples

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

By End User • Laboratories • Workplaces • Hospitals • Others The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Drug Screening industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.